In clinical practice, it is common to hear the terms induction and augmentation used interchangeably, but they represent two entirely different obstetric interventions. Labor induction is the artificial initiation of uterine contractions before the spontaneous onset of labor, done with the intent of achieving vaginal delivery. This means the woman is not yet in labor when the process begins. Conversely, labor augmentation is the stimulation of spontaneous contractions that are considered inadequate because of failed cervical dilation and fetal descent. Here, the woman's body has already started labor on its own, but the process requires assistance to progress effectively. Recognizing this distinction guides both the pharmacological approach and the intensity of maternal-fetal monitoring required in Nigerian delivery suites.
Deciding to interfere with the natural timing of birth requires a clear medical justification where the continuation of pregnancy poses a greater risk to the mother or baby than the intervention itself. Common maternal and fetal indications include:
Before attempting any induction, the midwife must evaluate the cervix to determine its favorability. A favorable, or ripe, cervix is soft, anterior, effaced, and partially dilated, which greatly increases the likelihood of a successful vaginal delivery. The Bishop score is the standard tool used to quantify this readiness, assigning points across five distinct pelvic parameters.
| Score Parameter | 0 Points | 1 Point | 2 Points | 3 Points |
|---|---|---|---|---|
| Dilatation (cm) | Closed | 1 - 2 | 3 - 4 | 5 - 6 |
| Effacement (%) | 0 - 30 | 40 - 50 | 60 - 70 | 80+ |
| Station | -3 | -2 | -1, 0 | +1, +2 |
| Consistency | Firm | Medium | Soft | - |
| Position | Posterior | Midposition | Anterior | - |
A total score of 8 or higher generally indicates a favorable cervix where oxytocin induction alone will likely succeed. A score below 6 suggests an unfavorable cervix that requires ripening before oxytocin is introduced.
When the Bishop score is low, attempting to jump straight to oxytocin often results in a failed induction and unnecessary operative delivery. Cervical ripening must occur first. Pharmacological methods frequently involve prostaglandin analogues such as dinoprostone (PGE2) gel or misoprostol (PGE1), which break down collagen fibers and soften the cervix. Misoprostol is widely used in resource-constrained settings due to its low cost and stability at room temperature, though careful dosing is vital to prevent uterine hyperstimulation.
Mechanical methods offer a drug-free alternative, physically dilating the cervical canal. The most common mechanical device is the transcervical Foley catheter, sometimes equipped with a saline-filled balloon that exerts mild pressure on the internal os. Alternatively, hygroscopic dilators like laminaria absorb endocervical fluid and slowly expand, opening the cervix safely over several hours.
Artificial rupture of the membranes, or amniotomy, is performed using an amnihook or similar sterile instrument to tear the amniotic sac. This procedure releases forewaters, brings the fetal presenting part directly against the lower uterine segment, and stimulates the natural production of prostaglandins. It can be used alone to induce labor or combined with oxytocin to augment sluggish contractions.
Before performing an amniotomy, the midwife must confirm vertex presentation and ensure the presenting part is well-apposed to the cervix to avoid umbilical cord prolapse. Immediately following the procedure, listening to the fetal heart rate is mandatory to rule out occult cord compression or rapid fetal distress. The midwife also inspects and records the color, amount, and odor of the amniotic fluid, noting any presence of meconium.
When administering intravenous oxytocin for induction or augmentation, precision is everything. Because individual uterine sensitivity varies widely, the hormone must always be delivered via an infusion pump using a dedicated secondary line plugged into a primary carrier fluid. The golden rule of oxytocin titration is to start low and go slow.
Typically, the infusion begins at a very low dose (such as 1 to 2 milliunits per minute) and is increased at intervals of 30 to 40 minutes only if uterine contractions are inadequate and fetal heart monitoring remains reassuring. Rapid dose escalation risks severe uterine hyperstimulation, which can compromise uteroplacental blood flow and cause fetal hypoxia. Constant, vigilant monitoring of contraction frequency, duration, and fetal well-being is required throughout the infusion.
Labor enhancement carries inherent risks, chief among them being uterine hyperstimulation—defined as excessive uterine activity leading to non-reassuring fetal heart patterns. Midwives must track contractions meticulously using a partograph, noting frequency, intensity, and relaxation time between contractions. Adequate resting tone between contractions is essential to restore blood flow to the placenta.
If hyperstimulation occurs, immediate action is required: